Neuropediatrics 2017; 48(S 01): S1-S45
DOI: 10.1055/s-0037-1603009
P – Poster
Georg Thieme Verlag KG Stuttgart · New York

Globotriaosylsphingosine (Lyso-GB3 bzw. Lyso-GL3), an Excellent Biomarker for Children with Fabry Disease

N. Karabul
1   Universtiäts-Kinderklinik RUB, Alexandrinenstraße, Bochum
,
T. Marquardt
2   Universitäts-Kinderklinik, Münster, Germany
,
M. Petersen
3   MVZ Dr. Eberhard and Partners, Dortmund, Germany
,
A. Beckmann
3   MVZ Dr. Eberhard and Partners, Dortmund, Germany
,
E. Namal
1   Universtiäts-Kinderklinik RUB, Alexandrinenstraße, Bochum
,
T. Lücke
1   Universtiäts-Kinderklinik RUB, Alexandrinenstraße, Bochum
› Author Affiliations
Further Information

Publication History

Publication Date:
26 April 2017 (online)

 

Introduction: Fabry disease (FD) is an X-linked disorder that affects both males and females and is caused by deficient activity of the lysosomal enzyme a-galactosidase A (a-Gal A).1 This leads to the accumulation of globotriaosylceramide (GL-3, Gb3), predominantly in the lysosomes of multiple cell types, and the elevation of globotriaosylsphingosine (lyso-GL-3, lyso-Gb3), the more water-soluble deacylated form of GL-3, in the plasma.2

Table 1 Lyso-GB3 levels

Start

6 Mo

12 Mo

Index patient

127

8.6

4.6

Brother

128

125

127

Mother

46

48

52

Uncle

86

42

39

Case Series We report a very interesting Fabry family with and without enzyme replacement therapy ([Table 1]).

Conclusion: Lyso-GB3 is an excellent marker for classic Fabry disease, especially for an excellent prognostic marker for Fabry children.

 
  • Reference

  • 1 Germain DP.. Fabry disease. Orphanet J Rare Dis 201;5:30. doi: 10.1186/1750-1172-5-30
  • 2 Aerts JM, Groener JE, Kuiper S. , et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A 2008; 105 (08) 2812-2817